<p>When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of the weight loss drugs. Now, the FDA is clamping down.</p>

When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of the weight loss drugs. Now, the FDA is clamping down.

Weight loss drugs may become harder to get. What does that mean for patients?

Hosted by Meghna Chakrabarti, On Point is a unique, curiosity-driven combination of original reporting, newsmaker interviews, first-person stories, and in-depth analysis, making the world more intelligible and humane. When the world is more complicated than ever, we aim to make sense of it together. On Point is produced by WBUR.

Share Weight loss drugs may become harder to get. What does that mean for patients?

Sign up to save your podcasts

Weight loss drugs may become harder to get. What does that mean for patients?

Weight loss drugs may become harder to get. What does that mean for patients?

More shows like On Point | Podcast

Science Friday

On the Media

Diane Rehm: On My Mind

Fresh Air

Here & Now Anytime

Reveal

Dear Sugars

Hidden Brain

The New Yorker Radio Hour

The NPR Politics Podcast

1A

The Daily

Circle Round

Endless Thread

Last Seen

Interesting Times with Ross Douthat

Post Reports

Throughline

Anything For Selena

The Ezra Klein Show

Short Run

The Common

Beyond All Repair